Form 4 for REVB REVELATION BIOSCIENCES, INC.
Accepted 2025-02-13 00:00:00 ET · period of report 2025-02-11 · accession 0000950170-25-020104 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-02-13 | 2025-02-11 | REVB | Zygmont Chester Stanley III | CFO | A - Grant | $3.87 | +15.0K | 15.1K | +53,743% | +$58.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-11 | A | A | 15,048 | $3.87 | 15,076 | I By Trust | — | — | (F1) Restricted Stock Grant under the 2021 Equity Incentive Plan. Vests 100% on date of grant. (F2) Shares are held by The Zygmont Family Trust Dated October 25, 2016, with respect to which Chester S Zygmont III is a trustee. |